Luciano Adorini - Net Worth and Insider Trading

Luciano Adorini Net Worth

The estimated net worth of Luciano Adorini is at least $203,471 dollars as of 2024-05-12. Luciano Adorini is the Chief Scientific Officer of Intercept Pharmaceuticals Inc and owns about 10,709 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $203,471. Details can be seen in Luciano Adorini's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luciano Adorini has not made any transactions after 2015-07-06 and currently still holds the listed stock(s).

Transaction Summary of Luciano Adorini

To

Luciano Adorini Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luciano Adorini owns 1 companies in total, including Intercept Pharmaceuticals Inc (ICPT) .

Click here to see the complete history of Luciano Adorini’s form 4 insider trades.

Insider Ownership Summary of Luciano Adorini

Ticker Comapny Transaction Date Type of Owner
ICPT Intercept Pharmaceuticals Inc 2015-07-06 Chief Scientific Officer

Luciano Adorini Latest Holdings Summary

Luciano Adorini currently owns a total of 1 stock. Luciano Adorini owns 10,709 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 6, 2015, with a value of $203,471.

Latest Holdings of Luciano Adorini

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ICPT Intercept Pharmaceuticals Inc 2015-07-06 10,709 19.00 203,471

Holding Weightings of Luciano Adorini


Luciano Adorini Form 4 Trading Tracker

According to the SEC Form 4 filings, Luciano Adorini has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 4,067 shares on July 6, 2015, which brought Luciano Adorini around $2 Million.

Insider Trading History of Luciano Adorini

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luciano Adorini Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Luciano Adorini Ownership Network

Ownership Network List of Luciano Adorini

No Data

Ownership Network Relation of Luciano Adorini


Luciano Adorini Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Luciano Adorini is the Chief Scientific Officer of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Luciano Adorini Mailing Address

Above is the net worth, insider trading, and ownership report for Luciano Adorini. You might contact Luciano Adorini via mailing address: C/o Intercept Pharmaceuticals, Inc., 18 Desbrosses St., New York Ny 10003.

Discussions on Luciano Adorini

No discussions yet.